Adalta Capital Management LLC Invitae Corp Transaction History

Adalta Capital Management LLC

  • $164 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$14.7 - $28.67 $83,422 - $162,702
-5,675 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$24.31 - $33.6 $13,005 - $17,976
-535 Reduced 8.62%
5,675 $161,000
Q2 2021

Aug 17, 2021
BUY
$26.09 - $40.4 $162,018 - $250,884
6,210 New
6,210 $209,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Adalta Capital Management LLC Portfolio

Follow Adalta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email